The Chris Wolfe Podcast: How Long Does Near VA Actually Improve With 1.25% Topical Pilocarpine?

episode

EyeCode Media not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from EyeCode Media

The Chris Wolfe Podcast:Your AMD Technology Isn’t the Problem—Your System Is 20 min · 21 Sep 2026

AWP: Beyond the Exam Room: Purpose, Myopia, and Population Health 54 min · 17 Sep 2026

The Chris Wolfe Podcast: The Power of Quality Supplements 48 min · 14 Sep 2026

The Chris Wolfe Podcast: All Things Caratenoids w/ Kirsten Ormsby 56 min · 18 May 2026

All episodes from EyeCode Media →

Report any issue

Source

Recorded16 Oct 2023

Publisherfeed.podbean.com ↗

Handlerec:9098018

Show notes

Today we discuss a poster presentation I had last week with Dr. Shane Kanner and others that we presented at the American Academy of Optometry in New Orleans. it's an analysis of the Virgo trial related to topical 1.25% Paolo Carpien with BID twice a day dosing. If you enjoyed this conversation, be sure to subscribe to this podcast for bi-weekly episodes or leave a review. Thank you to our listeners! -------------------------------- For our listeners, use the code 'EYECODEMEDIA22' for 10% off at check out for our Premiere Billing & Coding bundle or our EyeCode Billing & Coding course. Sharpen your billing and coding skills today and leave no money on the table! Show Sponsors: CooperVision MacuHealth EssilorLuxottica

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.